1. Home
  2. SRDX vs RAPP Comparison

SRDX vs RAPP Comparison

Compare SRDX & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • RAPP
  • Stock Information
  • Founded
  • SRDX 1979
  • RAPP 2022
  • Country
  • SRDX United States
  • RAPP United States
  • Employees
  • SRDX N/A
  • RAPP N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • RAPP
  • Sector
  • SRDX Health Care
  • RAPP
  • Exchange
  • SRDX Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • SRDX 457.0M
  • RAPP 439.4M
  • IPO Year
  • SRDX 1998
  • RAPP 2024
  • Fundamental
  • Price
  • SRDX $32.03
  • RAPP $26.20
  • Analyst Decision
  • SRDX Buy
  • RAPP Strong Buy
  • Analyst Count
  • SRDX 3
  • RAPP 4
  • Target Price
  • SRDX $43.00
  • RAPP $37.00
  • AVG Volume (30 Days)
  • SRDX 244.1K
  • RAPP 1.5M
  • Earning Date
  • SRDX 11-05-2025
  • RAPP 11-06-2025
  • Dividend Yield
  • SRDX N/A
  • RAPP N/A
  • EPS Growth
  • SRDX N/A
  • RAPP N/A
  • EPS
  • SRDX N/A
  • RAPP N/A
  • Revenue
  • SRDX $120,801,000.00
  • RAPP N/A
  • Revenue This Year
  • SRDX N/A
  • RAPP N/A
  • Revenue Next Year
  • SRDX $3.38
  • RAPP N/A
  • P/E Ratio
  • SRDX N/A
  • RAPP N/A
  • Revenue Growth
  • SRDX N/A
  • RAPP N/A
  • 52 Week Low
  • SRDX $26.00
  • RAPP $6.43
  • 52 Week High
  • SRDX $40.39
  • RAPP $42.27
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 52.07
  • RAPP 63.77
  • Support Level
  • SRDX $31.34
  • RAPP $22.06
  • Resistance Level
  • SRDX $33.17
  • RAPP $26.50
  • Average True Range (ATR)
  • SRDX 0.70
  • RAPP 3.15
  • MACD
  • SRDX -1.98
  • RAPP 0.70
  • Stochastic Oscillator
  • SRDX 92.20
  • RAPP 42.93

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: